Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials

By WIRB-Copernicus Group
Published: January 2019

Approximately 20% of cancer clinical trials will never be completed, because they fail to enroll enough participants to be able to answer the research question. Read this white paper to learn the impact that participant payments may play on clinical trial recruitment.

To learn more, register for our free white paper Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials.

Please enter in your information below. Fields with an * are required.

Please enter a valid email address to receive an email with a link to download the white paper.   

The WIRB-Copernicus Group® (WCG) is the world’s largest and most trusted provider of regulatory and ethical review services for human research.